Neurodegenerative Disease Market was estimated at $55.21 billion in 2024 and is projected to reach $99.21 billion by 2034 reflecting a robust CAGR of 7.88% over the forecast period from 2024 to 2034: Quintile Reports
IGC Pharma, Inc. (NYSE American: IGC) proudly announces that it won 2 awards in the PREPARE Challenge (Pioneering Research for Early Prediction of Alzheimer's and Related Dementias EUREKA Challenge), with its entry of the Mexican Health and Aging Study...
NeuraWorx Medical Technologies, Inc., a neurotechnology therapeutics company, announced today a partnership with prominent neuroscience venture builder and fund, Corundum Neuroscience.
